Thus, we set up a retrospective study to describe morbidity and mortality associated with baclofen overdose.
The objective of our study was to analyze the incidence of neurological complications while receiving ECMO, the risk factors, and to describe morbidity and mortality in a large cohort of patients in intensive care unit.
The prevalence of longstanding illness was used to describe morbidity in these groups.
Hence, it is possible to use morbidity data from the general practice registries to describe morbidity of the general population.
Although the SOFA score was originally used to describe morbidity, it was also used in mortality prediction.
The potential mechanisms involved in our findings range from the well described morbidity of hypoglycemia and hyperglycemia to oxidative stress triggered by acute fluctuations of glucose levels [ 3, 4, 24].
Catheter occlusion (in 11-40% patients), loss of venous access, infection 22-400%), embolism to other vessels including PE (~13%), and subsequent development of post-thrombotic syndrome 15-355%) are commonly described morbidities in patients with CVL-associated TE [ 21, 23, 25, 30].
Nonetheless, and even with its shortcomings, their effort is a welcome contribution to the surprisingly complex process of describing the morbidity of critical illness.
Finally, we included in our models occurrence of previous events in 2010 (hospitalisations because of macro-/microvascular events or with T2DM as main diagnosis) as variable describing the morbidity status of the patient.
